(Q33430554)

26 July 2017

On the use of hemagglutination-inhibition for influenza surveillance: surveillance data are predictive of influenza vaccine effectiveness (English)

1 reference

26 July 2017

1 reference

1

Wilfred Ndifon

1 reference

26 July 2017

Jonathan Dushoff

2

0 references

Simon A. Levin

series ordinal

3

object named as

Simon A Levin

1 reference

PubMed ID

19368786

26 July 2017

language of work or name

English

0 references

publication date

24 February 2009

1 reference

26 July 2017

1 reference

26 July 2017

27

1 reference

26 July 2017

18

1 reference

26 July 2017

2447-2452

1 reference

Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

The next influenza pandemic: can it be predicted?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Human influenza surveillance: the demand to expand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Quantifying influenza vaccine efficacy and antigenic distance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Epitope analysis for influenza vaccine design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

The evaluation of free influenza vaccination in health care workers in a medical center in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Predicting antigenic variants of influenza A/H3N2 viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Design and interpretation of vaccine field studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Influenza Immunization: Field Trial on a University Campus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Vaccination against influenza: a five-year study in the Post Office

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Variable efficacy of repeated annual influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

The evolution of human influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Do hospital employees benefit from the influenza vaccine? A placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

The World Health Organization: school health initiatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Cost-effectiveness of the influenza vaccine in a healthy, working-age population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

The effectiveness of vaccination against influenza in healthy, working adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Influenza vaccine efficacy in young, healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in spain from 1996 to 2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Reduced efficiency of influenza vaccine in prevention of influenza-like illness in working adults: a 7 month prospective survey in EDF Gaz de France employees, in Rhône-Alpes, 1996-1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Use of, effectiveness of, and attitudes regarding influenza vaccine among house staff.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

Mapping the antigenic and genetic evolution of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.047

10.1016/J.VACCINE.2009.02.047

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

19368786